Acutus Stock Analysis

The current indifference towards the small price fluctuations of Acutus Medical could raise concerns from investors as the firm it trading at a share price of 0.0 on very low momentum in volume. The company directors and management did not add any value to Acutus Medical investors in July. However, most investors can still diversify their portfolios with Acutus Medical to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer-term investment horizons.
Check out Trending Equities.

Search Stock Analysis 

The Acutus Medical stock analysis report makes it easy to digest most publicly released information about Acutus Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Acutus Stock analysis module also helps to analyze the Acutus Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Acutus Stock Analysis Notes

The company had not issued any dividends in recent years. Acutus Medical, Inc., an arrhythmia management company, provides electrophysiology products for the catheter-based treatment of cardiac arrhythmias in the United States and internationally. The company was founded in 2011 and is based in Carlsbad, California. Acutus Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 224 people. For more info on Acutus Medical please contact the company at 442-232-6080 or go to

Acutus Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Acutus Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Acutus Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Acutus Medical is not yet fully synchronised with the market data
Acutus Medical has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 3.63 M. Net Loss for the year was (100.44 M) with loss before overhead, payroll, taxes, and interest of (6.41 M).
Acutus Medical currently holds about 49.88 M in cash with (63.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 70.16.
Acutus Medical has a frail financial position based on the latest SEC disclosures

Acutus Medical Upcoming and Recent Events

Earnings reports are used by Acutus Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Acutus Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report12th of August 2021
Next Earnings Report11th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End17th of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Acutus Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Acutus Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Acutus Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Acutus Medical specific information freely available to individual and institutional investors to make a timely investment decision.
21st of July 2021
Unclassified Corporate Event. Unclassified Corporate Event
13th of July 2021
Unclassified Corporate Event
12th of July 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
21st of June 2021
Submission of Matters to a Vote of Security Holders
7th of June 2021
Entry into a Material Definitive Agreement
12th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
17th of March 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
11th of February 2021
Unclassified Corporate Event

Acutus Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 660.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acutus Medical's market, we take the total number of its shares issued and multiply it by Acutus Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Acutus Profitablity

Acutus Medical's profitability indicators refer to fundamental financial ratios that showcase Acutus Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Acutus Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Acutus Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Acutus Medical's profitability requires more research than a typical breakdown of Acutus Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.72) (0.78) 
Return on Average Equity 1.80  1.62 
Return on Invested Capital(0.88) (0.95) 
Return on Sales(11.40) (12.30) 

Management Efficiency

As of August 1, 2021, Return on Average Assets is expected to decline to -0.78. In addition to that, Return on Average Equity is expected to decline to 1.62. Acutus Medical Goodwill and Intangible Assets are projected to increase significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 17.68 Million. The current year Asset Turnover is expected to grow to 0.06, whereas Total Assets are forecasted to decline to about 163.8 M. Acutus Medical management efficiency ratios could be used to measure how well acutus medical manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2021
Book Value per Share 11.10  11.97 
Enterprise Value over EBIT(7.20) (7.77) 
Enterprise Value over EBITDA(7.63) (8.23) 
Price to Book Value 5.70  5.67 
Tangible Assets Book Value per Share 15.33  15.73 
Enterprise Value706.3 M702.2 M
Tangible Asset Value174.9 M148 M

Acutus Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acutus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acutus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Acutus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Acutus Medical Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Acutus Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio File Import Now


Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module
Check out Trending Equities. Note that the Acutus Medical information on this page should be used as a complementary analysis to other Acutus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Tools for Acutus Stock

When running Acutus Medical price analysis, check to measure Acutus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acutus Medical is operating at the current time. Most of Acutus Medical's value examination focuses on studying past and present price action to predict the probability of Acutus Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acutus Medical's price. Additionally, you may evaluate how the addition of Acutus Medical to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bond Directory
Find actively traded corporate debentures issued by US companies